Skip to content
Wenlo
Sign in
← Markets

Abbott Laboratories

Abbott Laboratories (ABT) — Form 144: Proposed sale of shares

144ABTFiled Nov 5, 2026, 4:22 PM ET

AI-generated summary

Officer Mary K. Moreland proposed to sell 3,500 shares of Abbott Laboratories common stock with an aggregate market value of $406,000. The shares were originally acquired through a vested restricted stock award on February 28, 2025. The sale is planned to be executed through UBS Financial Services, Inc. on or around November 5, 2026.

View original filing on SEC.gov (opens SEC EDGAR)

Key facts

Seller
Mary K. Moreland
Relationship
Officer
Shares to sell
3,500
Market value
$406,000.00
Approximate sale date
Nov 5, 2026
Broker
UBS Financial Services, Inc.
Acquired
Feb 28, 2025 · Restricted Stock Award Vested

More ABT filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.